Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China flag China · Delayed Price · Currency is CNY
21.03
-0.47 (-2.19%)
Sep 10, 2026, 2:10 PM CST

SHE:300702 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
94.81139.7155.9427.36-118.87204.68
Depreciation & Amortization
384.58356.85333.82305.13254.94193.42
Other Amortization
1.963.312.131.731.040.56
Loss (Gain) From Sale of Assets
-0.980.43-0.720.030.02-0.06
Asset Writedown & Restructuring Costs
36.915.512.672.098.2146.49
Loss (Gain) From Sale of Investments
5.036.4530.462.6959.65-52.72
Provision & Write-off of Bad Debts
-5.399.72-1.376.3-3.87-
Other Operating Activities
90.69116.6893.95181.392.426.91
Change in Accounts Receivable
40.86-167.82-363.45-242.68-269.46-315.07
Change in Inventory
237.1896.36-32.85-12.72-515.15-763.47
Change in Accounts Payable
5-106.28216.62-340.18450.23355.46
Change in Other Net Operating Assets
4.586.245.77-34.67-2.4640.51
Operating Cash Flow
906.95473.57344.64-43.9-48.7-262.23
Operating Cash Flow Growth
3471.91%37.41%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-327.2-357.77-168.95-316.81-527.01-736.39
Sale of Property, Plant & Equipment
4.444.721.423.564.110.77
Cash Acquisitions
---0.35--5.64
Investment in Securities
-25-20-13.752.522.5-118.7
Other Investing Activities
2.992.74-36.02-44.95-20.4257.59
Investing Cash Flow
-344.77-370.31-217.3-355.35-520.82-802.37

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-2,1161,8972,1841,409837.47
Total Debt Issued
1,9802,1161,8972,1841,409837.47
Long-Term Debt Repaid
--2,187-1,869-1,690-752.92-495.14
Lease Payments
-5.78-10.95-11.48-10.32--5.88
Total Debt Repaid
-2,024-2,187-1,869-1,690-752.92-495.14
Net Debt Issued (Repaid)
-43.34-71.1927.79494.47656.52342.33
Repurchase of Common Stock
---27.79--58-0.24
Common Dividends Paid
-55.33-57.96-70.19-51.12-69.42-112.43
Other Financing Activities
-151.67.1293.04-80-9.76-
Financing Cash Flow
-250.27-122.0322.85363.35519.34229.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-22.4-2.0320.43-1.8912.93-6.15
Net Cash Flow
289.51-20.8170.62-37.79-37.25-841.09

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
579.74115.8175.69-360.71-575.71-998.62
Free Cash Flow Growth
--34.09%----
Free Cash Flow Margin
16.54%3.78%6.68%-14.27%-21.59%-39.24%
Free Cash Flow Per Share
1.710.340.50-1.05-1.65-2.88
Levered Free Cash Flow
680.4366.77377.65-527.06-415.35-747.26
Unlevered Free Cash Flow
693.2793.73411.44-495.87-394.2-737.06
Free Cash Flow After Leases
573.97104.85164.21-371.03-575.71-1,004

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
43.6914.065.3-32.25-286.68-54.41
Change in Working Capital
299.34-165.09-172.19-630.52-342.22-681.5